Neal D Shore Selected Research

sipuleucel-T (APC8015)

1/2020	Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry.
12/2019	Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.
5/2017	Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial.
1/2016	The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma.
12/2015	Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies.
12/2015	Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer.
9/2015	A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.
5/2015	Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms.
2/2015	Combining immunotherapy and radiation for prostate cancer.
1/2014	The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neal D Shore Research Topics

Disease

99	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 10/2003
27	Neoplasms (Cancer) 01/2022 - 01/2012
14	Disease Progression 01/2022 - 11/2014
12	Pain (Aches) 01/2022 - 09/2012
12	Neoplasm Metastasis (Metastasis) 12/2021 - 07/2010
10	Fatigue 01/2022 - 09/2012
9	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2021 - 05/2008
6	Lower Urinary Tract Symptoms 09/2021 - 01/2016
4	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 10/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
3	Hypertension (High Blood Pressure) 01/2021 - 02/2015
3	Dysuria 10/2017 - 05/2008
3	Adenocarcinoma 02/2017 - 12/2008
2	Injection Site Reaction 01/2022 - 12/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2012
2	Circulating Neoplastic Cells 01/2020 - 01/2019
2	Infections 01/2019 - 09/2015
2	Back Pain (Backache) 01/2018 - 02/2016
2	Urinary Tract Infections (Urinary Tract Infection) 01/2018 - 12/2008
2	Hematuria 10/2017 - 09/2010
2	Diarrhea 10/2014 - 09/2012
2	Urinary Retention 09/2010 - 10/2003
1	Gynecomastia 01/2022
1	Cognitive Dysfunction 10/2021
1	Lymphatic Metastasis 05/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2021
1	Neutropenia 01/2020
1	Anemia 01/2020
1	Chronic Disease (Chronic Diseases) 12/2019

Drug/Important Bio-Agent (IBA)

35	AndrogensIBA 01/2022 - 12/2008
24	enzalutamideIBA 02/2022 - 09/2012
17	Testosterone (Sustanon)FDA Link 07/2022 - 12/2008
17	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 12/2008
15	Hormones (Hormone)IBA 01/2022 - 12/2008
15	sipuleucel-T (APC8015)FDA Link 01/2020 - 07/2010
13	Abiraterone AcetateIBA 01/2021 - 11/2014
12	Leuprolide (Lupron)FDA LinkGeneric 07/2022 - 12/2008
11	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2022 - 12/2008
11	Prednisone (Sone)FDA LinkGeneric 01/2021 - 11/2014
10	Androgen Receptors (Androgen Receptor)IBA 02/2022 - 09/2012
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
8	Docetaxel (Taxotere)FDA Link 01/2022 - 06/2015
6	relugolixIBA 07/2022 - 01/2020
6	abirateroneIBA 01/2022 - 11/2014
6	Pharmaceutical PreparationsIBA 10/2021 - 02/2015
5	SteamIBA 09/2021 - 01/2016
5	AntigensIBA 01/2020 - 02/2015
4	bicalutamide (Casodex)FDA LinkGeneric 09/2018 - 02/2016
4	Radium-223IBA 01/2018 - 04/2015
3	apalutamideIBA 01/2021 - 12/2016
3	VaccinesIBA 01/2016 - 04/2012
3	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 02/2013 - 12/2008
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2022 - 01/2021
2	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2022 - 01/2020
2	salicylhydroxamic acid (SHAM)IBA 09/2021 - 06/2017
2	antiarrhythmic peptide (AAP)IBA 01/2021 - 07/2017
2	RadiumIBA 10/2020 - 12/2015
2	PSMA ADCIBA 01/2020 - 01/2019
2	PROSTVACIBA 01/2019 - 01/2014
2	darolutamideIBA 01/2018 - 06/2017
2	Androgen Receptor AntagonistsIBA 01/2018 - 12/2016
2	Zoledronic Acid (Zometa)FDA Link 12/2016 - 08/2012
2	cabazitaxel FDA Link 12/2015 - 06/2015
2	IpilimumabIBA 05/2015 - 02/2015
1	talazoparibIBA 02/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	LY3023414IBA 01/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022
1	AntibodiesIBA 01/2022
1	DNA-Activated Protein KinaseIBA 01/2022
1	EstetrolIBA 06/2021
1	niraparibIBA 01/2021
1	Complementary DNA (cDNA)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2021
1	ElectrolytesIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019

Therapy/Procedure

64	Therapeutics 02/2022 - 03/2007
63	Castration 07/2022 - 07/2010
16	Immunotherapy 01/2020 - 07/2010
15	Drug Therapy (Chemotherapy) 12/2021 - 09/2012
7	Radiotherapy 01/2022 - 01/2014
5	Aftercare (After-Treatment) 10/2017 - 01/2017
2	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 05/2017
2	Injections 01/2022 - 01/2020
2	Orchiectomy (Orchidectomy) 03/2020 - 02/2016
2	Drug Tapering 11/2018 - 05/2018
2	Intramuscular Injections 09/2013 - 04/2010
2	Stents 05/2008 - 03/2007
1	Transurethral Resection of Bladder 01/2022
1	General Anesthesia 01/2022
1	Oral Administration 01/2021
1	Microspheres (Microsphere) 01/2021
1	Nephroureterectomy 01/2020
1	Antibiotic Prophylaxis 01/2019
1	Intravenous Infusions 01/2019